1.St Louis, JD, Jaggers, J. Left ventricular outflow tract obstruction. In: Nichols DG, Ungerleider RM, Spevak PJ (eds.). Critical Heart Disease in Infants and Children, 2nd edn. Mosby, Philadelphia, 2006, pp 609–623.
2.Mack, G, Silberbach, M. Aortic and pulmonary stenosis. Pediatr Rev 2000; 21: 79–85.
3.Reich, O. Aortic valve, congenital stenosis. In: Sievert H, Qureshi SA, Wilson N, Hijazi ZM (eds.). Percutaneous Interventions for Congenital Heart disease. Informa Healthcare, London, 2007, pp 153–162.
4.Roberts, WC, Ko, JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111: 920–925.
5.Godden, DJ, Sandhu, PS, Kerr, F. Stenosed bicuspid aortic valves in twins. Eur Heart J 1987; 8: 316–318.
6.McDonald, K, Maurer, BJ. Familial aortic valve disease: evidence for a genetic influence? Eur Heart J 1989; 10: 676–677.
7.McBride, KL, Riley, MF, Zender, GA, et al. NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling. Hum Mol Genet 2008; 17: 2886–2893.
8.Zhao, W, Wang, J, Shen, J, et al. Mutations in VEGFA are associated with congenital left ventricular outflow tract obstruction. Biochem Biophys Res Commun 2010; 396: 483–488.
9.Armstrong, EJ, Bischoff, J. Heart valve development: endothelial cell signaling and differentiation. Circ Res 2004; 95: 459–470.
10.Wagner, M, Siddiqui, MA. Signal transduction in early heart development (II): ventricular chamber specification, trabeculation, and heart valve formation. Exp Biol Med (Maywood) 2007; 232: 866–880.
11.Nguyen, KH. Congenital heart surgery nomenclature and database project: aortic valve disease. Ann Thorac Surg 2000; 69: S118–S131.
12.Griffin, HR, Hall, DH, Topf, A, et al. Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation. PLoS One 2009; 4: e4978.
13.Huez, I, Bornes, S, Bresson, D, Créancier, L, Prats, H. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 2001; 15: 2197–2210.
14.Meiron, M, Anunu, R, Scheinman, EJ, Hashmueli, S, Levi, BZ. New isoforms of VEGF are translated from alternative initiation CUG codons located in its 5′UTR. Biochem Biophys Res Commun 2001; 282: 1053–1060.
15.Tee, MK, Jaffe, RB. A precursor form of vascular endothelial growth factor arises by initiation from an upstream in-frame CUG codon. Biochem J 2001; 359: 219–226.
16.Dowlati, A. Hunting and trapping the vascular endothelial growth factor. J Clin Oncol 2010; 28: 185–187.
17.Ribeiro, LA, Bacci, ML, Seren, E, Tamanini, C, Forni, M. Characterization and differential expression of vascular endothelial growth factor isoforms and receptors in swine corpus luteum throughout estrous cycle. Mol Reprod Dev 2007; 74: 163–171.
18.Tischer, E, Mitchell, R, Hartman, T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947–11954.
19.Poltorak, Z, Cohen, T, Sivan, R, et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 1997; 272: 7151–7158.
20.Whittle, C, Gillespie, K, Harrison, R, Mathieson, PW, Harper, SJ. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin Sci (Lond) 1999; 97: 303–312.
21.Bates, DO, Cui, TG, Doughty, JM, et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002; 62: 4123–4131.
22.Lei, J, Jiang, A, Pei, D. Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183. Biochim Biophys Acta 1998; 1443: 400–406.
23.Houck, KA, Ferrara, N, Winer, J, Cachianes, G, Li, B, Leung, DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806–1814.
24.Nicholson, P, Yepiskoposyan, H, Metze, S, Zamudio Orozco, R, Kleinschmidt, N, Mühlemann, O. Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 2010; 67: 677–700.